Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science Startup Investors in Asia in November 2024

Last updated: Nov 2024 A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Asia. We rank investors based on the number of investments they made in Life science companies from Asia. We update this investor list every month.

Top 50 Life Science Startup Investors in Asia in November 2024

Investor	Life Science Asia investments
Hillhouse Investment	6
Prox Ventures	5
HongShan	5
Qiming Venture Partners	5
Huagai Capital	4
UntroD Capital	4
Mitsubishi UFJ Capital	4
Osaka University Venture Capital	4
UTEC - The University of Tokyo Edge Capital Partners	4
Nissay Capital	4
EFung Capital	4
BioVenture	3
Entrepreneurship Relay Group	3
Nippon Venture Capital	3
ULTIMA	3
WuXi AppTec	3
SMBC Venture Capital	3
EDBI	3
Legend Capital	3
Anzu Partners	3
Vinno Capital	3
MiraclePlus	3
ASBV	3
Bits x Bites	2
Senshu Ikeda Capital	2
Puhua Capital	2
Zoo Capital	2
Med-Fine Capital	2
Green Pine Capital Partners	2
Huimei Capital	2
Orient Securities Capital Investment	2
Sherpa Healthcare Partners	2
Mizuho Capital	2
BOHE Angel Fund	2
Oriental Fortune Capital	2
BMC	2
Eight Roads Ventures	2
Incubate Fund	2
Northern Light Venture Capital	2
Gaw Capital Partners	2
Lilly Asia Ventures	2
Innoangel Fund	2
CDH Investments	2
Highlight Capital	2
SBI Investment	2
Lucion	2
CentreGold Capital	2
Eisai	2
Loyal Valley Capital	2
Real Tech Japan	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

dinii — Dinii is a mobile order platform for take-out shops.
Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
China, United States, United Kingdom

Portfolio highlights

Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Dongchedi — The company's platform users interests and hobbies and automatically recommends content, information, and vehicle quotations related to new cars and used cars, providing users with knowledge and car industry information.
XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
RD Technologies — RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Baijun Biotech — Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.
Ai Sensing Technology — Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.
Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Investment focus

Manufacturing, Biotechnology, Robotics
Funding Round, Seed, Series A
Japan, Singapore, India

Portfolio highlights

Revorf — Revorf analyzes data and develops AI-related to infectious diseases and healthcare.
MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Emulsion Flow Technologies — Emulsion Flow Technologies offers rare metal recycling, utilizing emulsion flow technology, emulsion.

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Investment focus

Information Technology, Software, Health Care
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

A-Wave — A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.
Tribeau — Tribute is a word-of-mouth app for aesthetic medicine for cosmetic surgeries, cosmetic dermatologists, and orthodontists who are not covered by health insurance.
AI model — AI model specializes in the development and transformation of real-like virtual models for modeling on E-commerce platforms.

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Investment focus

Biotechnology, Manufacturing, Health Care
Funding Round, Seed, Series A
Japan

Portfolio highlights

Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Red Arrow Therapeutics — Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Funding Round
Japan, United States, Singapore

Portfolio highlights

Estie — Estie is a Development of AI / machine learning algorithm and new business in real estate company.
Liminal — Advanced battery inspection and metrology with ultrasound and machine learning
SUN METALON — Next Generation Sustainable Metal Manufacturing

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Investment focus

Health Care, Internet, Medical
Funding Round, Seed, Series A
Japan, United States, Ethiopia

Portfolio highlights

Tribeau — Tribute is a word-of-mouth app for aesthetic medicine for cosmetic surgeries, cosmetic dermatologists, and orthodontists who are not covered by health insurance.
Space One — Space One specializes in the production and development of rockets and offers innovative solutions for space transportation services.
Qlay — Qlay is an AI-automated global engineer hiring platform

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Investment focus

Medical, Life Science, Biotechnology
Series A, Angel, Series C
China

Portfolio highlights

Shanghai Bioprofile — Shanghai Bioprofile is a metabonomics technology service provider.
Lingyun Microelectronics — Lingyun Microelectronics is a manufacturer of high-speed digital-analog hybrid interfaces and control processors.
Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Investment focus

Software, Health Care, Information Technology
Funding Round, Series A, Seed
Japan, United States

Portfolio highlights

Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Renalys Pharma — Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
Arsaga Partners — Arsaga Partners, Inc., "develop with the fastest and highest quality" as concept, is a one-stop IT system development company.- All functions necessary for IT system development such as IT strategy consulting, UX/UI consulting, planning, engineering, designing, maintenance and operations are provided through our one-stop solution.- With engineers accounting for over 90% of our company structure we can work directly with our clients. - Our motto is to providing services at a reasonable cost without outsourcing and to bring our Japanese omotenashi spirit to our development services. - We think of Digital transformation (DX) Not as a trendy word, but as IT system development that truly contributes to our clients' business needs.Main Services - One-stop IT System Development Business, Start-up/New IT Business Consulting, Enterprise System/New Business Planning and Development(Digital Transformation/DX), Web System Planning and Development, Application Planning and DevelopmentKey Clients - Nippon Steel Kowa Real Estate Co., Ltd., Mitsubishi Estate, ShionogiV-CUBE, Mizuho Securities, Sciseed inc.

ULTIMA is an investment management firm.

Investment focus

Hardware, Software, Agriculture
Angel, Series A
China

Portfolio highlights

Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series A, Series B, Series C
United States, China, Israel

Portfolio highlights

D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Investment focus

Information Technology, Health Care, Software
Funding Round, Series B, Series A
Japan, United States, Singapore

Portfolio highlights

Quanmatic — Quanmatic is an information and technology company that provides algorithms development and solutions to bridge quantum technologies.
Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.
Okuma Diamond Device — Okuma Diamond Device supplies cutting-edge technologies that make diamond semiconductors vital.

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Investment focus

Biotechnology, Software, Health Care
Series C, Series B, Series D
United States, Singapore, China

Portfolio highlights

Zinc Money — A suite of comprehensive solutions to help families navigate international education for their children and ensure a sound financial foundation for their academic journey.
Sunbird Bio — Sunbird Bio, a biotech company, is developing protein-based diagnostic tests that empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer.
Arta Finance — Arta is a digital wealth platform offering unifying your investments, financial planning, tax and estate planning in one. Access elite private investment fund managers, along with intelligent investment tools for public markets.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
Ensurge Medical — Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.
Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Investment focus

Biotechnology, Software, Manufacturing
Series A, Series B, Funding Round
United States, Canada, Spain

Portfolio highlights

6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
CytoTronics — CytoTronics allows you to visualize live cell function in real time and at scale using a revolutionary approach to studying cell biology, powered by microchips.

Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.

Investment focus

Manufacturing, Semiconductor, Hardware
Series A, Seed, Series B
China, United States

Portfolio highlights

Glazero Technology — Established in Dec 2020, Glazero is a brand that provides smart home solutions to global markets. It focuses on AIot smart home products, covering smart security, smart lighting and smart cleaning products. Glazero starts from the North American home appliance market, and sells through cross-border e-commerce platforms.
Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Angel, Pre-Seed
China, United States, Singapore

Portfolio highlights

Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.

ASBV focuses on early and mid-term venture capital investments.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Angel
China, Australia, Hong Kong

Portfolio highlights

Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.

Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.

Investment focus

Biotechnology, Food and Beverage, Food Processing
Series A, Seed, Series B
China, Israel, Singapore

Portfolio highlights

Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
Mojia Bioscience — Mojia Bioscience is a biotechnology company.
Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.

Senshu Ikeda Capital offers financial consultancy services.

Investment focus

Software, Internet, Information Technology
Funding Round, Seed, Series A
Japan

Portfolio highlights

iYell — iYell Mortgage Platform consists of three pillars, Media that can be used for marketing, Technology to make the procedure more efficient.
Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, United Kingdom, United States

Portfolio highlights

Glbizzia — Glbizzia is a company specializing in genetic testing, data utilization, and biological breeding platforms, focusing on high-throughput omics big data analysis, intelligent omics experiments, and scientific research consulting.
Garen Semiconductor — Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide).
ICleague Technology — ICleague Technology to satisfy situations requiring high processing power, high bandwidth, and low power consumption.

Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.

Investment focus

Artificial Intelligence, Software, Biotechnology
Seed, Series A, Series B
China, Hong Kong, United States

Portfolio highlights

TabbyML — Tabby is an open-source AI coding assistant that empowers developers to code faster and smarter. Discover a self-contained alternative to GitHub Copilot, tailored for your development needs.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
Puju Biotechnology — PuJu Biotech focuses on developing an engineering process platform for bioactive filling materials and is dedicated to continuously launching world-class high-end regenerative medicine material products to benefit the vast number of people seeking beauty, as well as providing new material solutions for medical beauty and anti-aging for all agegroups.

Green Pine Capital Partners is a venture capital firm.

Investment focus

Artificial Intelligence, Manufacturing, Software
Series A, Angel, Series B
China, United States, Canada

Portfolio highlights

Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
Neurogin — Neurogin is a bioelectronics company that provides reliable monitoring and auxiliary diagnostic tools for clinical and health institutions and focuses on advanced engineering methods for brain science research and clinical diagnosis.
Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Sensview — Sensview specializes in the development and production of solid-state imaging chips and detector modules.
Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.

Orient Securities Capital Investment is an private equity fund business platform.

Investment focus

Health Care, Manufacturing, Software
Series A, Series D, Series C
China

Portfolio highlights

News Dart — News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.
HiStarlink — HiStarlink is a commercial company that makes communication technology like space-borne laser communication terminals and core devices. The main product matrix covers aerospace Advanced core optoelectronic devices, ultra-high-speed communication algorithms, laser communication terminals, and satellite-to-ground laser ground receiving systems.
Shiyu Precision — Shiyu Precision is a high-tech enterprise specializing in the research, development and manufacture of semiconductor automation equipment.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Investment focus

Information Technology, Software, Internet
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

THE PHAGE — The phage is a medical device company that focuses on developing AI technology to predict postprandial blood glucose levels.
elleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.

BOHE Angel Fund is an investment Fund.

Investment focus

Health Care, Medical, Biotechnology
Angel, Series A, Seed
China

Portfolio highlights

Levostar — Levostar is a biotechnology company that specializes in the development and manufacture of cell and gene therapy products.
QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
Tyligand Bioscience — Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT

BMC engaged in asset management, investment management and consulting.

Investment focus

CAD, Medical, Computer
Seed, Series B
China

Portfolio highlights

Shengshi Technology — Shengshi Technology is a CFD experimental simulation AI-based platform that does medical engineering research on cardiovascular diseases.
Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.
Timesintelli — Timesintelli focuses on the development of various end-side artificial intelligence processing chips. The company provides support for a wide range of end-side devices, such as voice, vision, image, display, and other multi-modal intelligent human-computer interactions. Starting from the needs of the landing scene, through the domain-specificarchitecture and customized chip design in the AIoT era where everything is connected.

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Investment focus

Software, Health Care, Information Technology
Series B, Series A, Series C
United States, China, India

Portfolio highlights

Odaseva — Odaseva is the leading enterprise data platform for Salesforce. Industry leaders rely on Odaseva to keep data protected, compliant, and agile.
Feon — Feon is pioneering new-molecule-based liquid electrolytes for advanced batteries. We are a "pharmaceutical company" in the battery space, creating "new drug molecules" to treat the "diseases" of next generation batteries.
Hero Software — Hero Software offers cloud software solutions.

Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.

Investment focus

Software, Information Technology, E-Commerce
Seed, Funding Round, Series A
Japan, United States, India

Portfolio highlights

Vieu — Learn about us, our team, our backers and the story behind Vieu.
KOMPEITO — Office de Yasai is an online platform that enables users to order and get vegetables delivered to their offices. The platform’s operations are based in Tokyo, Japan.
Phi — Phi is a social gaming platform that focuses on 'on-chain Identity' using ENS and wallet activity. It allows users to build their web3 cities based on their wallet activities. The platform also offers a variety of features such as Silver Gas Saver, Supersonic Bat, Gold Gas Saver, Hypersonic Bat, Iron Gas Guzzler, and Ethereum Wallpaper.Phi also provides a user guide for its users to understand how to play and access Phi Land, and how to create their Phi Land. The platform is designed to be immersive and interactive, providing a unique gaming experience for its users.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
Tuliu.com — Tuliu.com is a comprehensive online platform for land transfers in China. The company integrates information like land area, prices, and development trends, forms an evaluation standard and provides farmers with free land value evaluation services.
weshare — Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide throughcontinuous exploration and technologies.

Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.

Investment focus

Information Technology, Hotel, Property Management
Series A, Seed, Series B
China, Singapore, United States

Portfolio highlights

Blackpanda — Asia's premier digital forensics and cyber incident response firm.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Gusto Collective — First brandtech group using the latest technology to help brands create content and experiences across the physical and virtual worlds.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
Chimagen Biosciences — Chimagen Biosciences is a company that is creating a novel class of multi-functional monoclonal antibodies for cancer therapy.
Positive Sequence Biology — Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Innoangel Fund is an investment firm that invests in early stage companies.

Investment focus

Artificial Intelligence, Software, Manufacturing
Angel, Seed, Series A
China, Canada, Hong Kong

Portfolio highlights

Rushen Robotics — Rushen Robotics focuses on the domains of rehabilitation and fitness, and is committed to building modular and human-machine integrated rehabilitation robots.
Zhiyuan Shenlan — Zhiyuan Shenlan focuses on data-driven biomolecule design and manufacturing.
Saiyun Biotechnology — Saiyun Biotechnology is committed to the development of cutting-edge delivery carrier technology and breakthrough medicinal therapies.

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Investment focus

Manufacturing, Health Care, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Yida Technology — SaaS, Data
Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Investment focus

Information Technology, Software, Financial Services
Series B, Funding Round, Series A
Japan, South Korea, United States

Portfolio highlights

BasiGo — BasiGo is an early-stage e-mobility start-up looking to revolutionize the public transportation sector by providing matatu owners with a cost-effective electric alternative to diesel buses.
AI model — AI model specializes in the development and transformation of real-like virtual models for modeling on E-commerce platforms.
Ultra Social — Ultra Social offers marketing support, management creator production, and tiktok live production services.

Lucion is an influential professional venture capital institute.

Investment focus

Biotechnology, Medical, Manufacturing
Series A, Series B, Seed
China

Portfolio highlights

Keylights — Keylights focuses on the research and development, production, and sales of in vitro diagnostic instruments, it supplies domestic and international consumers with ultra-stable, high-performance, and cost-effective goods and CDMO services.
Runfu Power — Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
ThunderBio Innovation — ThunderBio Innovation engages in business includes tumor screening based on the digital biopsy technology of microfluidic chip, etc.

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Investment focus

Medical Device, Artificial Intelligence, Internet
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
Virgo Surgical Video Solutions — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series C, Funding Round
Japan, United States, China

Portfolio highlights

Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
LIFENET INSURANCE COMPANY — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.

Loyal Valley Capital is a thematic, research-driven private equity firm.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series C, Series B, Series A
China, United States, Hong Kong

Portfolio highlights

Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
DP Technology — DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D.DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trainedlarge science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.
DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.

Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.

Investment focus

Manufacturing, Biotechnology, Medical
Funding Round, Series A, Seed
Japan, Singapore, Austria

Portfolio highlights

Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.

Investors by industry